Company Overview of Carigent Therapeutics, Inc.
Carigent Therapeutics, Inc., a biotechnology company, develops therapeutic agents. It offers a drug delivery platform for releasing therapeutic agents, targeting therapy to physiological sites, tethering surface ligands, and combining multiple agents. The company’s product is used in various applications, such as genetic, systemic, and oncology diseases. Carigent Therapeutics, Inc. was incorporated in 2006 and is based in New Haven, Connecticut.
5 Science Park
New Haven, CT 06520
Founded in 2006
Key Executives for Carigent Therapeutics, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Carigent Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.